In most species, the zona pellucida (ZP), an extracellular matrix surrounding the mammalian oocyte, is composed of three glycoproteins: ZPA, ZPB and ZPC. Based mainly on results with mice, the site of zona pellucida biosynthesis has been suggested to be exclusively in the oocyte cytoplasm. However, evidence is accumulating that among various species cumulus/granulosa cells may be involved. Because knowledge of ZP biosynthesis in primates is lacking, we used the common marmoset (Callithrix jacchus) to acquire information about the localization and the site of synthesis of ZP proteins in this species. Using antibodies against synthetic ZPA and ZPC peptides, immunoreactivity was found in the marmoset ZP and in surrounding cumulus cells. Interestingly, the amounts of ZPA and ZPC proteins expressed appeared to differ depending on the stage of folliculogenesis. RT -PCR analysis of mRNA from marmoset oocytes and from oocyte-free follicle cells revealed expression of ZPA, ZPB and ZPC in oocytes and in follicle cells of different stages of marmoset monkey folliculogenesis. Our data suggest that the biosynthesis of marmoset ZPA, ZPB and ZPC proteins takes place both in oocytes and in follicle cells of different follicle stages, although the abundance of ZP glycoproteins may differ depending on the individual ZP protein.
Introduction
The zona pellucida (ZP) is a translucent glycoprotein matrix enclosing the mammalian oocyte and the early embryo until implantation and plays a critical role in the process of fertilization. For example, the ZP is the site of the sperm acrosome reaction. It provides specific binding sites for sperm and the alteration in structure after sperm -oolemma contact prevents polyspermia (Yanagimachi, 1994) . After fertilization, the ZP is required to maintain the juxtaposition of the precompaction blastomeres as well as to protect the early embryo against physical damage and detrimental external influences (Herrler and Beier, 2000) .
Depending on the species, the ZP consists of three to four different glycoproteins encoded by three classes of ZP genes (Hasegawa et al., 1991; Topper et al., 1997; Sinowatz et al., 2001; Spargo and Hope, 2003) that serve different functions. The proteins show considerable micro-heterogeneity due to differences in glycosylation. In mouse and in human, the ZP is mainly composed of three ZP glycoproteins (Bleil and Wassarman, 1980; Bercegeay et al., 1995) whose functions appear to differ, although differences between species may occur. In the mouse, it has been shown that ZPB is a homodimeric filament crosslinker that stabilizes the heterodimeric ZPA/ZPC protein network (Green, 1997) . However, binding of recombinant bonnet monkey (Macaca radiata) ZPB (which is different from the mouse ZPB1 gene) to capacitated as well as to acrosome-reacted sperm has been reported and thus may indicate a functional role of ZPB during fertilization (Govind et al., 2001) . This is of interest because it has been demonstrated in several species, including mouse and human, that it is ZPC that mediates primary sperm -ZP binding and induction of the acrosome reaction (K.D. Hinsch and E.Hinsch, 1999; Miller et al., 2002; Wassarman, 2002) , while ZPA has been shown to serve as a secondary receptor (E. Hinsch et al., 1997; Tsubamoto et al., 1999; Howes et al., 2001; Jansen et al., 2001; Howes and Jones, 2002) . Similar to other nonrodent species studied, three ZP proteins have been demonstrated for two Old World non-human primate species [e.g. the bonnet monkey (Macaca radiata) and the cynomolgus monkey (Macaca fascicularis)] (Kolluri et al., 1995; Paterson et al., 1996; Gupta et al., 1997; Jethanandani et al., 1998) , as well as for the marmoset (Callithrix jacchus) (EMBL-database, accession no. Y10822, Y10767, S71825). However, several studies in different species suggest a possibility of functional differences of individual glycoproteins during fertilization compared with the mouse (Prasad et al., 2000) .
It is not only function that may differ between species groups; although information is still incomplete, the site of de novo synthesis of ZP glycoproteins may also differ. For example, expression of mouse ZP proteins has been shown exclusively for the oocyte (Epifano et al., 1995; El Mestrah et al., 2002) , while in other mammals (rabbit, dog, pig and cow), ZP protein expression has also been reported in follicle cells (Sinowatz et al., 2001) . For some avian species, in contrast, the synthesis of a mammalian ZPC protein homologue seems to be restricted to granulosa cells (Waclawek et al., 1998; Takeuchi et al., 1999; Sasanami et al., 2002) .
For mammals, although information on the sequences of the ZP proteins exists, knowledge about the site and timing of synthesis of the ZP proteins is scarce (Roller et al., 1989; Epifano et al., 1995; Martinez et al., 1996; Jewgenow and Fickel, 1999) . In cynomolgus monkeys the contribution of granulosa cells to the expression of ZP genes has been demonstrated by Martinez et al. (1996) . ZPA and ZPC mRNA was localized in granulosa cells, whereas in these cells no ZPB mRNA was found at any stage of folliculogenesis (Martinez et al., 1996) . To date, in the marmoset monkey only the synthetic site of one single zona pellucida protein, ZPC, has been described. In this study, mRNA expression was shown to be exclusively localized in the oocyte (Thillai-Koothan et al., 1993) in contrast to results reported for the cynomolgus monkey (Martinez et al., 1996) .
The aim of the present study was therefore to provide information about ZP gene transcription and ZP protein localization in the marmoset ovary to serve as a basis for studies of factors influencing ZP synthesis throughout folliculogenesis.
Materials and methods

Collection of oocytes and follicle cells
The ovarian cycle of female marmoset monkeys was monitored via cyclic changes in plasma progesterone concentration. Ten to 14 days postovulation, luteolysis was induced by the i.m. application of 0.8 mg of cloprostenol, an analogue of prostaglandin F 2a (Estrumate; Pitman-Moore, Germany). Ovary pairs were collected on day 5 or 6 of the follicular phase (day 0 ¼ day of injection of prostaglandin F 2a ) as previously described (Gilchrist et al., 1995) in Leibovitz L-15 medium (GibcoBRL, Germany) with 5% heatinactivated fetal bovine serum (FBS; Biochrom KG, Germany), supplemented with 0.5 mmol/l sodium pyruvate and 5% gentamycin sulphate (Sigma Aldrich Chemie, Germany). After removal of excess tissue, fat and blood, follicles were dissected in Leibovitz L-15 medium using watchmaker's forceps under a dissecting microscope on a heated stage at 378C under laminar flow and sorted according to the presence or absence of antrum and size. The diameter of follicles was measured with a calibrated ocular micrometer. Preantral follicles were defined as follicles with a diameter ,400 mm (class 1). The periantral and antral follicles were grouped according to size: class 2 (400-599 mm), class 3 (600 -999 mm), and class 4 ($1000 mm) as described by Gilchrist et al. (1995) . Based on criteria of granulosa cell colour, density, and uniformity of distribution, follicles judged to be atretic were discarded. The selected follicles were then punctured. The oocytes were mechanically stripped of their surrounding cumulus cells and collected and stored separately from cumulus and granulosa cells. Careful microscopical examination of the oocytes ensured that neither cumulus cells nor cumulus cell residues were attached to the cell samples. Both oocytes and follicle cells were stored in RNAlater w (Ambion, UK) at 2208C.
Anti-ZP-peptide antisera
Generation and characterization of the antisera (AS) against synthetic ZPA and ZPC peptides have been described previously (K.D. Hinsch et al., 1994; E.Hinsch et al., 1997 E.Hinsch et al., , 1998a . We also generated antisera against synthetic marmoset ZPB peptides. As a result, we obtained by enzyme-linked immunosorbent assay high antibody titres against the peptide employed, but using immunoblotting and immunohistochemical techniques the antisera did not react with the ZPB protein.
Immunohistochemistry
Intact marmoset ovaries were fixed in Methacarn, cut into sections of 4 mm, and processed as previously described (K.D. Hinsch et al., 1994; E.Hinsch et al., 1999) . Specimens were treated with anti-ZPA and -ZPC antibodies (AS ZP2-20 diluted 1:50; AS ZP3-6 diluted 1:100) for 60 min. Antigenantibody reaction was visualized with anti-rabbit Ig antibodies (dilution 1:100; Dako Diagnostica, Germany) using the peroxidase-antiperoxidase method (Dako) and 3,3 0 -diaminobenzidine (DAB; Sigma Aldrich Chemie, Germany) as colour substrate. Finally, sections were counterstained with haematoxylin (Sigma Aldrich Chemie). As negative control, sections were incubated with preimmune serum diluted 1:50 and processed as described above.
Immune transmission electron microscopy
Generation of ultrathin sections and immunodetection of ZP proteins has been described previously (E. Hinsch et al., 1998b) . Briefly, marmoset ovaries were fixed and subsequently embedded in LR-White (Plano, Germany). Ultrathin sections were cut on an LKB ultramicrotome (Sweden) and collected on nickel grids (Plano). After blocking of non-specific binding sites, sections were exposed to antisera for 75 min (AS ZP2-20 diluted 1:10; AS ZP3-6 diluted 1:5); as negative controls, corresponding preimmune sera in the same dilutions as the antisera were used. Subsequently, sections were incubated with biotinylated anti-rabbit IgG (Sigma Aldrich Chemie; diluted 1:20 for AS ZP2-20 and 1:40 for AS ZP3-6) for 30 min followed by incubation with streptavidin conjugated to colloidal gold (particle size of 20 nm; 1:40 dilution; Bio Cell, UK) for 30 min at room temperature.
Sections were then washed and fixed in 1% (v/v) glutaraldehyde/Trisbuffered saline for 5 min. Finally, the probes were stained for 20 min with 2% (w/v) uranyl acetate and examined and photographed using a Zeiss transmission electron microscope LEO 906.
RT -PCR of ZP mRNA mRNA from isolated oocytes and oocyte-free follicle cells from marmoset ovaries was prepared using an MPG guanidine direct mRNA purification kit (CPG, USA). The following two types of cell samples were assayed: oocytes derived from follicles with defined diameters (class 1, 2, 3 and 4) and the corresponding oocyte-free follicle cells. For each class, mRNA from seven oocytes and their respective follicle cell masses was used.
An RT reaction was performed with Omniscript RT Kit (Qiagen, Germany) according to the manufacturer's instructions. Subsequently, 2 ml of each RT reaction product (cDNA) was used for PCR in a final volume of 50 ml containing 2.5 IU Taq polymerase (PanScript DNA Polymerase; PanBiotech, Germany), NH 4 -buffer [16 mmol/l (NH 4 ) 2 SO 4 , 50 mmol/l Tris -HCl pH 8.8, 0.1% Tween 20], 2 mmol/l MgCl 2 (all from Pan-Biotech), 0.25 mmol/l dNTP (Gene-craft, Germany) and 100 pmol of each primer (Table I) . After denaturation for 4 min at 948C, amplification was carried out for 35 cycles at 948C for 45 s, and primer annealing was performed according to specific annealing temperatures for 45 s, at 728C for 90 s, and with a final extension at 728C for 5 min. The concentration of all components as well as the specific annealing temperatures was optimized. As negative control, PCR was performed with distilled water instead of the RT reaction product. Amplification products were sequenced by MWG Biotech (Germany).
Primer sequences were determined by applying PC/gene software (IntelliGenetics). All three marmoset ZP gene-specific primer pairs were deduced from published marmoset sequences (accession no. Y10822, Y10767, S71824). As positive control, mRNA amplification of the housekeeping gene human glyceraldehyde-3-phosphate dehydrogenase (HGAPDH, accession no. NM_002046) was performed. In addition to the HGAPDH primer pair, a second primer pair (HIGAPDH) based on the human DNA sequence of GAPDH (accession no. J04038) was designed to search for possible genomic DNA (gDNA) contamination within the probes.
Besides these controls, expression of an oocyte-specific protein gene, BMP15 (Table I) , was used in order to determine if contaminating oocyte mRNA was present in the follicle cell preparation (Dube et al., 1998; Braw-Tal, 2002) .
Results
Immunohistochemical localization of ZPA and ZPC proteins
In previous studies, antisera were generated against synthetic peptides corresponding to highly conserved ZPA and ZPC epitopes. Here, the reactivity of these antisera, anti-ZPA antiserum AS ZP2-20 and anti-ZPC antiserum AS ZP3-6, were analysed in sections of marmoset ovaries.
ZPA localized in marmoset ZP and follicle cells varied according to the stage of folliculogenesis ( Figure 1A , A1 -A3). In the layer of cells that surrounds the primordial follicles, sporadic staining for ZPA was observed (Figure 1, A1, I ). Primary follicles displayed immunoreactivity in the early developing ZP as well as in the ooplasm and in the surrounding follicle cell layer (Figure 1, A1, II) . For later preantral developmental stages (Figure 1 , A2, III and A3, IV) a positive reaction continued to be detected in all three regions. In small preantral follicles (A2, III) as well as in large preantral follicles (A3, IV), staining of the ZP appeared as a homogeneous, brownish ring of substrate deposition surrounding the oocyte. A faint but definitive staining was observed in the ooplasm of the oocytes of these follicles (A1 and A2, asterisk). Additionally, a strong colour development was detected within the marmoset follicle cells of both early and late preantral follicles (A2, A3). An intense color development within the ZP as well as in the surrounding follicle cells was also observed in small antral follicles (not shown). Immunohistochemical localization of ZPA and ZPC proteins in the marmoset ovary. Methacarn-fixed and paraffin-embedded sections were incubated with antisera AS ZP2-20 (A, A1-A3; 1:50 dilution) and AS ZP3-6 (B, B1-B3; 1:100 dilution). Control sections were treated with preimmune serum (C, C1-C3; 1:50 dilution). Binding of antibodies was visualized using the peroxidase-antiperoxidase method. q ¼ ooplasm; ZP ¼ zona pellucida; FC ¼ follicle cells; I ¼ primordial follicle; II ¼ primary follicle; III ¼ small preantral follicle; IV ¼ large preantral follicle; V ¼ small antral follicle. With the exception of primordial follicles, ZPC protein was mainly found in the ZP of marmoset oocytes independent of the developmental stage (Figure 1, B) , with only faint staining observed in follicle cells of all developmental stages. ZPC was detected in oocytes of primary follicles (B1, II) as well as in small (B2, III) and large preantral follicles (B3, IV) and small antral follicles (B3, V). The ZP was visualized as a distinct brown ring. Compared to ZPA, less immunolabelling was visible in the ooplasm (B2 and B3, asterisks). In the follicle cells of primordial (B1, I), primary (B1, II), and small preantral follicles (B2, III), little colour deposition was observed, which suggested a low level of ZPC protein immunoreactivity. Only faint staining of follicle cells, slightly above background, was visible in large preantral and small antral follicles (B3, IV and V). Sections treated with the preimmune serum did not display any specific colour development (Figure 1, C, C1 -C3 ).
Immune transmission electron microscopy
The ultrastructure of the marmoset zona pellucida and the distribution of ZPA and ZPC were investigated with immunoelectron microscopy using anti-ZP antisera AS ZP2-20 and AS ZP3-6 (Figure 2 ). In ultrathin sections of preantral follicles from marmoset ovaries, ZPA protein was localized in the zona pellucida (ZP) and in cumulus cells (CC) (Figure 2A ) as well as in the ooplasm (not shown). The distribution of gold particles in the ZP matrix (ZP) appeared as a uniform and homogeneous pattern (Figure 2A , arrowheads). Gold particles were also observed in the cytoplasm (CP) of the follicle cells ( Figure 2D, arrowheads) . Immunoreactive material in the follicle cells was less abundant than in the ZP but clearly above background levels. Only a few gold grains, slightly above background, were observed in the ooplasm (not shown).
When the anti-ZPC antiserum AS ZP3-6 was applied to sections of preantral marmoset follicles, immunolabelling was also observed in the ZP of the oocyte. However, labelling distribution was much less homogeneous ( Figure 2B) . A more intense immunoreaction was apparent in the inner part of the zona pellucida (arrowheads). Only small amounts of immunoreactive material were detected in the outer areas of ZP towards the follicle cells ( Figure 2B, asterisk) . This faint immunolabelling may be connected with the indentation of ZP and surrounding follicle cells ( Figure 2B, rhombus) . It is important to note that compared to the distribution of ZPA protein, the surrounding follicle cells ( Figure 2E ) showed much less immunoreactivity. A little immunoreactive material that was slightly above background was found in the ooplasm (not shown).
In control sections incubated with the preimmune serum, few gold grains could be observed in the ZP ( Figure 2C ) and in cumulus cells ( Figure 2F ).
RT -PCR results
RT -PCR revealed that three different ZP mRNA's are expressed in marmoset oocytes (Figure 3) . In oocytes from follicles with diameters ,400 mm (preantral; Figure 3A ), 400-599 mm (periantral; Figure 3B ), 600-999 mm (small antral follicles; Figure 3C ), and $ 1000 mm (large antral, Figure 3D ), specific intron-spanning primers (Table I) for the marmoset ZPA, ZPB and ZPC genes amplified cDNA fragments of the expected base pair lengths corresponding to ZP mRNA: 465 bp for ZPB (lane 1), 362 bp for ZPA (lane 2) and 388 bp for ZPC (lane 3) were used. Although these were not the results of a quantitative PCR analysis, the intensity of the ZPB and ZPA amplification products appeared to be more pronounced than the bands resulting from ZPC primers. As a positive control, RT-PCR for HGAPDH (Table I ) resulted in an amplicon of 300 bp ( Figure 3A-D, lane 4) .
Messenger RNA for ZPA, ZPB, and ZPC genes were detected in follicle cells of all follicle groups examined ( Figure 4A-D) . In follicle cells from follicles with diameters , 400 mm (preantral; Figure  4A ), 400-599 mm (periantral; Figure 4B ), 600-999 mm (small antral follicles; Figure 4C ), and $1000 mm (large antral, Figure 4D ), While HIGAPDH was amplified, possible gDNA contamination in the template was excluded by the omission of the reverse trancriptase step yielding no amplification products after PCR (not shown). For the evaluation of possible oocyte mRNA contamination in templates derived from follicle cells, the occurrence of BMP 15 mRNA was examined. The use of BMP 15 primers (Table I) did not result in amplification of a cDNA fragment (not shown). Control experiments using water instead of the template for RT-PCR revealed no amplification products (not shown).
After sequencing the respective ZP amplicons, an identity of 99% for ZPB and ZPA and of 100% for ZPC with the marmoset ZP nucleotide sequences deduced from the NCBI database was observed (not shown).
Discussion
In this study, we have investigated the presence and distribution of ZPA and ZPC proteins in marmoset ovarian tissue using anti-ZP-peptide antisera. At the protein level, ZPB protein could not be localized in marmost ovaries because no appropriate anti-ZPB antisera were available. We generated a number of antisera against marmoset ZPB synthetic peptides; the antibodies, however, reacted with the corresponding synthetic peptides that were used as antigen but did not detect the ZPB polypeptide. We assume that the peptide used for immunization leads to the production of antibodies that react with the linear synthetic peptide. However, the antibodies might not cross-react with the ZPB protein because the epitope is perhaps not available for antibody detection (e.g. through folding of the protein or steric hindrance because of glycosylation). Our efforts to obtain adequate anti-primate ZPB antisera from other groups were, for various reasons, also not successful. However, we succeeded in demonstrating gene expression of all three ZP mRNA (ZPB, ZPA and ZPC) by RT-PCR in the marmoset ovary.
Examination by both immunohistochemical and immune transmission electron microscopy revealed that AS ZP2-20 recognized ZPA protein in the marmoset ZP, both in oocyte cytoplasm as well as in surrounding follicle cells. In spite of apparent structural differences of the inner and outer zona pellucida indicated by the visible bilamellar morphology of marmoset ZP (Gilchrist et al., 1997) , distribution of ZPA protein was relatively homogeneous over the entire zona matrix.
The antigenic ZPA detected inside the ooplasm may reflect ZPA protein synthesis and transport of ZPA during oogenesis. These findings are consistent with data from other species generally indicating the presence of immunoreactive material in the ooplasm and in the zona pellucida (Martinez et al., 1996; E.Hinsch et al., 1998b; Eberspaecher et al., 2001) .
The localization of ZPA antigenic material in marmoset follicle cells indicates that ZPA protein is synthesized in these cells. This finding contrasts with results from humans (E. Hinsch et al., 1998b) and an Old World non-human primate species (cynomolgus monkey) (Martinez et al., 1996) . Our RT-PCR results confirmed that ZP gene transcription appears to take place not only in marmoset oocytes but also in follicle cells, indicating a significant difference from Old World primates in ZPA synthesis. ZPA protein was found in marmoset ZP, in the ooplasm, and in follicle cells, but the abundance of ZPA protein varied depending on the stage of folliculogenesis. With the exception of primordial follicles where the oocyte did not exhibit positive immunostaining, all other stages of oocyte development studied clearly demonstrated the presence of ZPA protein and its de novo synthesis in both oocytes and follicle cells.
Interestingly, the distribution of the ZPC protein differed from ZPA. Anti-ZPC-peptide antiserum AS ZP3-6 produced strong staining in the ZP together with faint staining in the follicle cells. In contrast to Grootenhuis et al. (1996) , we have shown in this study that primordial follicles exhibit faint ZPA and ZPC protein immunoreactivity in follicle cells while no circular staining around or within the oocyte could be observed. They reported that by using monoclonal antibodies against recombinant human ZPC in marmosets, small dots of immunoreactive ZP were found in 60% of the primordial follicles but granulosa cells were not stained. In the present study, however, histochemical results that were supported by RT-PCR demonstrate that in the marmoset, the ZPC gene is expressed in the follicle cells as well as in the oocytes, although the follicle cells may be less active in ZPC than in ZPA protein synthesis.
The marmoset ZP was stained in primary follicles for both ZPA and ZPC; furthermore, ZPA-and faint ZPC-stained follicle cells were visible in primary follicles. Immune transmission electron microscopy further revealed a different distribution for ZPC protein within the ZP, with a greater concentration of ZPC molecules in the inner ZP. This contrasted with the uniform distribution of ZPA protein throughout the ZP. E. demonstrated in the murine model bilamellar deposition of ZPC protein using a mousespecific anti-ZPC antiserum, indicating the possibility of layered arrangements of specific ZP protein, even in species where the intact ZP is not visibly bilaminar and the ZP is entirely synthesized by the oocyte. To various degrees, a bilamellar structure for ZP has been described for several species, including cat (Andrews et al., 1992) , mouse (Baranska et al., 1975) , hamster (Keefe et al., 1997) , pig and rabbit (Dunbar et al., 2001) , and human (Nikas et al., 1994) . This phenomenon can clearly be observed for the marmoset (Gilchrist et al., 1997) . The functional significance of this bilaminar characteristic as well as the differential molecular composition is still unclear. However, in vitro sperm binding studies in the marmoset suggest that firm sperm binding occurs primarily at the interface of the two layers where a higher number of ZPC molecules are located (K.Bogner, unpublished results).
The number of species where ZP gene expression takes place in follicle cells as well as in the oocyte appears to outnumber those where ZP gene expression is found exclusively in oocytes. The only species demonstrating expression of ZPA, ZPB and ZPC mRNA exclusively by the oocyte is the mouse (Epifano et al., 1995; El Mestrah et al., 2002) . In other mammalian species studied, although the oocyte is always involved, additional expression of one or more ZP genes in somatic follicular cells was observed (Sinowatz et al., 2001) . Lee and Dunbar (1993) have demonstrated that in rabbit, a 55 kDa protein, which is the proposed counterpart of the murine ZPB protein, was expressed in both oocyte and granulosa cells. A similar finding has been reported for bovine ZPC and porcine ZPB (Kolle et al., 1996 (Kolle et al., , 1998 . In contrast, for avian species thus far investigated (chicken and the quail), the synthesis of a protein homologous to the ZPC protein can be localized exclusively to the granulosa cells (Waclawek et al., 1998; Takeuchi et al., 1999; Sasanami et al., 2002) . With respect to marmoset, the cell types in the ovary that synthesize particular ZP glycoproteins vary between groups, and our knowledge is still incomplete. From Aitkin's laboratory, an oocyte-specific expression of ZPC has been demonstrated for marmosets using in situ hybridization (Thillai-Koothan et al., 1993) , a result consistent with their studies of ZPC protein distribution (Grootenhuis et al., 1996) . Results of both of these studies contrast with those obtained in the present study. Investigations with other monkey species showed a possible contribution of granulosa cells by the transcription of the ZPA and ZPC genes in the cynomolgus monkey (Macaca fascicularis) while ZPB distribution in this species was restricted to the oocyte (Martinez et al., 1996) .
Sequential gene expression during oogenesis and folliculogenesis and communication and cooperation of different follicle cell compartments during ZP formation, as well as allocation of function to the individual ZP protein which serves either as structural and/or as functional protein, are of particular relevance for the understanding of the fertilization process. However, particular information about species-specific differences of ZP protein expression during oogenesis is not only important for the understanding of cellular and molecular events that regulate oocyte development, it also has strong implications for introducing effective, long-term culture systems for oocytes (e.g. for human in vitro fertilization or for retaining genetic diversity in rare species) and for the design of immunocontraceptive vaccines.
In this study, we demonstrated for the marmoset that ZP proteins are transcribed and expressed in almost all stages of folliculogenesis. Although no quantitative estimation of ZP protein expression (e.g. through real time PCR) is provided in this study, our data suggest that the amounts in which ZP proteins are expressed appear to differ depending on the stage of folliculogenesis. Sequential transcription and synthesis of ZP proteins has been demonstrated in several species (Roller et al., 1989; Epifano et al., 1995; Martinez et al., 1996; Jewgenow and Fickel, 1999; Prasad et al., 2000) .
In the mouse, ZPB transcripts were detected after growth initiation of the oocytes; ZPA and ZPC proteins are coordinately expressed in mouse oocytes during the growth phase. During ovulation, the level of ZPC mRNA declines and is no longer detectable in fertilized eggs (Roller et al., 1989) .
Because of its essential role during fertilization, the ZP is an attractive target for contraceptive vaccination. Active immunization can cause either permanent or reversible infertility. Irreversible infertility might be useful for the control of certain animal populations (e.g. dogs, stray cats, horses, or elephants). Permanent infertility would be induced by the disruption of normal ovarian oogenesis, while interfering at the level of sperm -egg interaction might lead to reversible infertility. Sterilization by vaccination with ZP proteins could be desirable for the development of animal contraceptives, but is detrimental for fertility control in humans or rare animal species. Therefore, it is important to acquire knowledge about the site and time course of expression of individual ZP proteins that are targets for immune contraception during ovarian follicular development.
In the marmoset ovary, we demonstrated that ZPA but not ZPC protein can be detected in the layer of cells that surrounds the primordial follicle, indicating that sequential ZP protein expression occurs at this stage of folliculogenesis. ZPA antigens in marmoset primordial follicles could induce irreversible infertility because the destruction of early follicles would exhaust the resting oocyte pool. If reversible infertility should be desired in this species, ZPC might be a more suitable contraceptive agent.
Sequential expression of zona pellucida protein genes during oogenesis has also been reported for the domestic cat (Jewgenow and Fickel, 1999) . In this species, initial expression of ZP proteins was observed in some primary follicles and in secondary follicles. ZPB was expressed in growing primary follicles, while all three ZP mRNA were detectable in secondary follicles. In the cynomolgus monkey, ZPC was expressed as early as the primordial follicle stage, and ZPA was detected in primary follicles; ZPB, however, was detected first in the secondary follicle stage. The results obtained in our study support the hypothesis that species specificity in ZP expression during oogenesis is evident and that the time frames of ZP protein synthesis differ between species.
To the best of our knowledge, this is the first study investigating ZPB, ZPA and ZPC gene expression in the marmoset monkey using RT -PCR. This method has proven to be very effective for determination of qualitative mRNA transcription. Results demonstrated unequivocally that both the oocyte and follicle cells express ZPB, ZPA and ZPC. Because this is not a quantitative method, conclusions about the differential expression of these proteins throughout the different stages of follicular development cannot yet be made. This also holds true for the level of expression of the three ZP proteins in oocytes or follicle cells. In agreement with the immunocytochemical data presented above, however, results appear to suggest a lower level of expression of ZPC compared to the other proteins. We are presently undertaking quantitative PCR analysis to confirm these findings.
In this set of data, intron-spanning ZP primer pairs were used for RT -PCR. Although HIGAPDH primers suggest the presence of gDNA contamination in the RNA preparations, we observed that no ZP gene fragments were amplified using gDNA as a template. These results suggest that the generation of ZP amplicons is specific for ZP mRNA. mRNA expression for all three ZP genes was observed in marmoset oocytes and follicle cells, thus indicating that de novosynthesis of ZP proteins occurs in both cell types. Sequencing of the amplicons obtained by RT-PCR with templates from oocytes and follicle cells confirmed that they definitively represent marmoset ZPA, ZPB and ZPC nucleotide sequences. Purity of follicle cell preparation was proven by negative RT -PCR results with the 'oocyte-specific' BMP15 gene (Dube et al., 1998; Braw-Tal, 2002) expression in follicle cells.
In summary, we have presented here the first study to address gene expression in oocytes and follicle cells of all marmoset ZP proteins yet known according to follicular developmental stages. We conclusively demonstrated that ZPB, ZPA and ZPC gene expression was reliably localized in marmoset oocytes as well as in marmoset follicle cells. This is in agreement with our immunohistochemical studies that localized ZPA and ZPC protein in both oocytes and follicle cells. These results indicate that the oocyte is presumably the primary site of production of ZP proteins but that follicle cells are also involved in ZP protein de novosynthesis. Further investigation is warranted to clarify the stage-specific ZP protein synthesis patterns and to investigate whether or not the follicle cell-produced ZP proteins differ structurally from those produced in the oocyte either in the sequence of the protein or in glycosylation pattern, and whether they may have a differential localization and function in the outer layer of the bilamellar marmoset ZP.
